Sitagliptin Dose Determination Study

NCT01530178 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Sitagliptin
DRUG: Placebo Oral Tablet

Sponsor

Albert Einstein College of Medicine